Markets › India › NSE › AUROPHARMA

Aurobindo Pharma Ltd

NSE:AUROPHARMAHealthcareNSE:CNX200NSE:CNX500

₹1,621.40−2.73%At closeAt close · Mon 19 Oct · ≈ AED 62.65 · Market cap $10.05B · Next earnings Mon 9 Nov

Beat (%) vs consensus · next report Mon 9 Nov

DateMon, 9 Nov 2026

EPS estimate19.11

Revenue estimate99,780.5m

Currency—

Report	EPS estimate	EPS actual	EPS surprise	Revenue estimate (m)	Revenue actual (m)	Revenue surprise
2026-08-04	17.26	17.86	+3.5%	90,053.7	91,503.5	+1.6%
2026-05-20	16.33	15.86	−2.9%	87,366.7	88,533.4	+1.3%
2026-02-09	15.94	15.67	−1.7%	84,657.1	86,459.0	+2.1%
2025-11-05	15.24	14.61	−4.1%	81,417.7	82,860.0	+1.8%
2025-08-03	16.68	14.20	−14.9%	82,105.7	78,681.4	−4.2%
2025-05-26	17.57	15.56	−11.4%	82,769.6	83,821.2	+1.3%
2025-02-07	15.54	14.56	−6.3%	78,653.0	79,785.0	+1.4%
2024-11-08	16.05	14.00	−12.8%	77,875.8	77,960.7	+0.1%
2024-08-11	16.20	15.69	−3.1%	76,094.7	75,670.2	−0.6%
2024-05-24	14.53	17.59	+21.1%	73,378.7	75,801.5	+3.3%
2024-02-10	15.48	16.04	+3.6%	73,753.9	73,517.8	−0.3%
2023-11-09	10.54	12.83	+21.7%	68,086.2	72,194.2	+6.0%

Currency not supplied by the earnings feedUpdated Tue 4 Aug ·

ⓘ

Surprise is actual minus consensus, as a share of the consensus.